IL4I1 and melanoma: These observations were confirmed in human melanoma samples with high IL4i1 expression (45, 46), and in 2020, a study from Sadik and colleagues (26) described the enrichment of immunosuppressive cells such as MDSCs and regulatory T cells as a common feature of malignancies with high IL4i1 expression.